# 바이오스페이스 일일 뉴스 리포트 - 2026년 03월 02일


## 주요 헤드라인

1. **Uncertainty Looms Over Pharma’s Legal Strategy as States Challenge New Vaccine Schedule (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/uncertainty-looms-over-pharmas-legal-strategy-as-states-challenge-new-vaccine-schedule>

2. **Uncertainty Looms Over Pharma’s Legal Strategy as States Challenge New Vaccine Schedule (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/uncertainty-looms-over-pharmas-legal-strategy-as-states-challenge-new-vaccine-schedule>

3. **After Sarepta’s Annus Horribilis, Elevidys Sales Expected To Continue Downward Spiral (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/after-sareptas-annus-horribilis-elevidys-sales-expected-to-continue-downward-spiral>

4. **After Sarepta’s Annus Horribilis, Elevidys Sales Expected To Continue Downward Spiral (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/after-sareptas-annus-horribilis-elevidys-sales-expected-to-continue-downward-spiral>

5. **Opinion (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/opinion-new-painkillers-critical-to-fight-opioid-epidemic-broader-pain-crisis>

6. **Opinion (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/opinion-new-painkillers-critical-to-fight-opioid-epidemic-broader-pain-crisis>

7. **Novo Returns to Pre-Wegovy Valuation as Lilly Makes History as First Ever $1T Pharma (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novo-returns-to-pre-wegovy-valuation-as-lilly-makes-history-as-first-ever-1t-pharma>


---
*2026년 03월 02일 바이오스페이스 뉴스 피드에서 생성된 리포트*